Biocon plans ₹4,500-cr QIP to raise stake in Biologics unit: Kiran Shaw

Biocon is planning a ₹4,500 crore fundraise to increase promoter stake in Biocon Biologics and convert structured venture debt into equity, aiming to improve profitability. The company is also considering a merger with its parent company as an alternative to an IPO due to market uncertainties.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/iaU2g47
via IFTTT